Supplements Exposed: What Really Works for Prostate Health

DrTalks

G. Espinosa

Microultrasound vs. MRI-Guided Biopsy for Prostate Cancer Diagnosis …

Laurence Klotz

Year in Review: Prostate Cancer - 2024 Insights and Exciting Prospec…

Jason Hafron

Prostate Cancer Ablation - The Best Option For Your Intermediate Ris…

Preston Sprenkle

Prostate Cancer Detection: MRI, Image Quality, and PI-RADS Techniques

International Cancer Imaging Society (ICIS)

P. Asbach

Robot-assisted Radical Prostatectomy (RARP)

Challenges in Laparoscopy & Robotics (CILR)

B. Rocco

Year in Review - Prostate Cancer

Oncology 2024 Year in Review

K. Tawagi

NARUS 2025 Insights: Surgical Approach to LN Metastasis on PSMA Scan

Isaac Kim

Hormonal Therapy and Thrombosis Risk With Testosterone

Scripps Health

D. Houghton

Robot-Assisted Radical Prostatectomy: Surgical Techniques and Sexual…

RENALC-BLADDR-PROSCA 2024

A. Tewari

My Journey to Partial Gland Ablation of Prostate Cancer

Focal Therapy Society

H. Lepor

HoLEP in a Patient in Urinary Retention With Metastatic Prostate Can…

Pieter Uvin

Year in Review 2024 - Managing Advanced Prostate Cancer

Oncology 2024 Year in Review

R. Dreicer

Focal Therapy for Anterior Tumors: HIFU, Cryo, IRE or Robotic - Whic…

Focal Therapy Society

A. Lebastchi, W. Phin Tan, P. Stricker, A. Villers

The HERO Trial: Relugolix vs. Leuprolide in Advanced Prostate Cancer

Duke Cancer Institute

D. George

Management of Large and Locally Advanced Renal Masses: The Past, Pre…

Ithaar Derweesh

AUA2025 Insights: Radical Cystectomy vs Bladder Sparing Therapy for …

John Gore

Year in Review - Key Clinical Trials in Prostate Cancer

GWU Urology

ASCO® GU 2025 Summary: Perioperative Strategies in MIBC - Key Trial …

Insights from 2025 ASCO® GU Annual Meeting

E. Plimack

There Is NOT Enough Evidence for FT to Be Considered a Standard Trea…

Focal Therapy Society

R. Olivares